Georgina Kontou

Associate Director of Business Development Beacon Biosignals

Georgina Kontou, PhD, is an Associate Director of Business Development at Beacon Biosignals, where she focuses on leveraging sleep EEG insights to help biopharma partners de-risk and accelerate drug development. Georgina holds a PhD in Neuroscience from UCL, where she investigated how mitochondrial distribution in inhibitory neurons modulates brain network activity. She subsequently completed a postdoctoral fellowship at the AstraZeneca–Tufts Laboratory for Basic and Translational Neuroscience, contributing to early-stage drug discovery programs. Georgina later transitioned into life science consulting, working with ClearView Healthcare Partners and Kx Advisors (a BGB Group company). There, she partnered with pharmaceutical companies on a broad range of strategic initiatives, from go-to-market planning with commercial teams to evidence generation strategies supporting clinical development.